A general perspective from our studies is that persistent basal HER3 tyrosine phosphorylation underlies PI3K/AKT/mTOR activation by directly binding PI3K p85/p110 subunits in most HNSCC cases that do not harbor PIK3CA mutations. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.